DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.

Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...

Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

DexCom (NASDAQ:DXCM) shares, currently trading at $85.48 with a market capitalization of $33.38 billion, maintained their ...

Valued at $33 billion by market cap, DexCom, Inc. (DXCM) is a global leader in continuous glucose monitoring (CGM) technology ...

DexCom stock shines with strong fourth quarter and full-year 2024 preliminary results, driven by innovation and global expansion. Explore if it's a buy or hold for your portfolio!

ŌURA is fast becoming a household name in the wearable technology sector, thanks to its namesake smart ring. The device ...

DexCom (NASDAQ:DXCM – Get Free Report) was upgraded by stock analysts at Robert W. Baird from a “neutral” rating to an ...

DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...